![Ypke van Oosterhout](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ypke van Oosterhout active positions
Companies | Position | Start | End |
---|---|---|---|
Xenikos BV
![]() Xenikos BV Medical SpecialtiesHealth Technology Xenikos BV focuses on the development of immunotherapies for the treatment of patients suffering from immune diseases. It is developing a combination of two toxin-loaded anti-T-cell antibodies, T-Guard, as a therapeutic tool for resetting the body's immune system in T-cell mediated diseases. The company was founded by Ypek van Oosterhout in September 2009 and is headquartered in Nijmegen, the Netherlands. | Director/Board Member | 31/12/2008 | - |
Chief Executive Officer | 31/12/2008 | - | |
Founder | 31/12/2008 | - |
Career history of Ypke van Oosterhout
Statistics
International
Netherlands | 2 |
Operational
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Founder | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Xenikos BV
![]() Xenikos BV Medical SpecialtiesHealth Technology Xenikos BV focuses on the development of immunotherapies for the treatment of patients suffering from immune diseases. It is developing a combination of two toxin-loaded anti-T-cell antibodies, T-Guard, as a therapeutic tool for resetting the body's immune system in T-cell mediated diseases. The company was founded by Ypek van Oosterhout in September 2009 and is headquartered in Nijmegen, the Netherlands. | Health Technology |
- Stock Market
- Insiders
- Ypke van Oosterhout
- Experience